Duncan Steven Wood's most recent trade in MEI Pharma Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MEI Pharma Inc | Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 3.17 per share. | 17 May 2024 | 3,100 | 4,359 (0%) | 0% | 3.2 | 9,827 | Common Stock |
| MEI Pharma Inc | Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Duncan Steven Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) |